Intuitive Surgical

• 8-KGovernance change

  Filed Jul 27

  Bylaw amendments tighten shareholder nomination rules, requiring proponents to solicit holders of 67% of outstanding shares under universal proxy rules.

• 10-QQ2 FY2026Positive

  Filed Jul 21

  Rising da Vinci procedures drove instruments sales; more operating leases tied system revenue closer to utilization.

  • Revenue$2.9BYoY +18.5%
  • Net income$818.1MYoY +24.3%

• 8-KPositiveEarningsNew guidance

  Filed Jul 16

  More procedures, higher da Vinci leasing revenue and a larger installed base drove revenue growth.

• 8-KLeadership change

  Filed May 28

  Taylor Patton succeeds Henry Charlton as Chief Commercial and Marketing Officer; Charlton becomes SVP of Global Business Operations.

• 8-KBuybackExecutive payShareholder vote

  Filed May 4

  Board expands share-repurchase authorization; stockholders enlarge the incentive plan’s share reserve and extend its term to 2036.

• 10-QQ1 FY2026Positive

  Filed Apr 22

  More da Vinci procedures and da Vinci 5 placements drove sales; product cost improvements lifted margins despite tariffs.

  • Revenue$2.8BYoY +23.0%
  • Net income$821.5MYoY +17.6%

• 8-KPositiveEarningsNew guidance

  Filed Apr 21

  Rising da Vinci and Ion procedures and more da Vinci 5 placements fueled revenue growth.

• 8-KPositiveDeal completed

  Filed Mar 2

  Completed da Vinci and Ion distribution acquisition extends direct operations to Italy, Spain and Portugal.

• 10-KFY2025Positive

  Filed Feb 3

  Da Vinci 5 adoption and rising procedure volumes drove growth, while usage-based leases shifted more revenue toward future utilization.

  • Revenue$10.1BYoY +20.5%
  • Net income$2.9BYoY +23.0%

• 8-KPositiveEarningsNew guidance

  Filed Jan 22

  Rising procedure volumes and da Vinci 5 placements drove growth; 2026 outlook points to slower procedure growth and tariff pressure on margins.

• 8-KPositiveEarningsNew guidance

  Filed Jan 14

  da Vinci 5 placements surged alongside procedure-driven revenue growth; 2026 procedure guidance points to a slower pace.

Coverage: 10-K filings filed since Feb 3, 2026; 10-Q since Apr 22, 2026; 8-K since Jan 14, 2026.

Request longer coverage

Company data: Wikidata Q2743863